MedTrace Logo

A Follow-up Study of Dragon Study (NCT03520764): to Assess the Growth and Immune-related Outcomes

NCT05476289 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 226

Last updated 2024-09-19

No results posted yet for this study

Summary

Dragon follow-up aims to evaluate the growth, allergies, and infections of Chinese subjects up to four years of age who completed the intervention period visit (from Day 0-44 to Week 17) of the Dragon study \[EBB16SI08406\]. This study aims to provide insights into the role of usage of a partially hydrolyzed formula with added synbiotics in early life children's growth and immune-related outcome up to 4 years of age.

Conditions

  • Healthy Nutrition

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Nutricia Early Life Nutrition (Shanghai) Co., Ltd

    collaborator UNKNOWN

  • Danone Nutricia

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-29
Primary Completion
2021-11-17
Completion
2023-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05476289 on ClinicalTrials.gov